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resumo 
 
 
O tecido conjuntivo parece estar envolvido na génese de diversas condições 
patológicas. O aumento da rigidez do tecido conjuntivo, resultante da fibrose, 
pode constituir um factor importante no mecanismo patogénico da dor crónica 
resistente a fármacos (Langevin & Sherman, 2007). Por outro lado, os 
nucleótidos extracelulares parecem estar envolvidos na fisiopatologia da dor 
crónica (Burnstock, 2001). Assim, este estudo teve como objectivo averiguar o 
efeito dos nucleótidos de adenina e uridina na proliferação e síntese de 
colagénio tipo I de fibroblastos do tecido subcutâneo de rato em cultura. 
Os resultados obtidos mostram que a incubação com UTP (0.3-100 M, n=5) 
induz um aumento da proliferação e da produção de colagénio tipo I, o qual é 
dependente da concentração. Contrariamente, o agonista selectivo dos 
receptores P2Y2, o MRS 2768 (10 µM, n=3), não teve qualquer efeito no que 
se refere à proliferação, mas diminuiu significativamente (P<0.05) a síntese de 
colagénio tipo I. Uma vez que o aumento da produção de colagénio induzida 
pelo UTP (100 µM) foi proporcional ao aumento do número de células 
(proliferação celular),podemos especular que este aumento se deve ao 
aumento do número de células per si do que a uma maior actividade sintética 
de cada célula. Assim, ao normalizar os valores do colagénio tipo I em relação 
aos valores obtidos do MTT para os mesmos momentos/dias, deixamos de 
observar diferenças estatisticamente significativas entre o controlo e as células 
expostas ao UTP.  
Uma vez que os receptores P2Y2 não parecem estar envolvidos nesta resposta 
do UTP (100 µM), esta poderá estar a ser mediada pela activação dos 
receptores P2Y4 e/ou P2Y6. Considerando que o RB-2 (10 µM, n=5), um 
antagonista não selectivo que actua preferencialmente no subtipo de 
receptores P2Y4, não foi capaz de modificar a resposta induzida pelo UTP (100 
µM), os receptores P2Y4 parecem também não estar envolvidos. Por outro 
lado, o MRS 2578 (100 nM), um antagonista selectivo dos receptores P2Y6, 
atenuou de forma significativa o aumento induzido pelo UTP (100 µM).  
A corroborar os nossos resultados, uma análise imunocitoquímica mostrou 
uma imunorreactividade positiva contra os receptores P2Y2 e P2Y6, mostrando 
um padrão de marcação citoplasmático/membranar, o qual é típico para este 
tipo de receptores, ao contrário do padrão nuclear exibido pelo anticorpo 
contra os receptores P2Y4.  
Relativamente ao envolvimento dos receptores sensíveis ao ADP, os 
resultados obtidos mostraram que o ADPβS (10-100 µM, n=3-6), um análogo 
estável do ADP, não parece induzir efeitos significativamente diferentes 
(P>0.05) na proliferação celular. Contudo, a sua incubação continuada 
aumentou a produção de colagénio tipo I de forma dependente da 
concentração (P<0.05). De modo a identificar os receptores purinérgicos 
envolvidos neste efeito, testamos o ADPβS (100 µM) na presença do MRS 
2179 (0.3 µM), do AR-C 66096 (0.1 µM), e do MRS 2211 (10 µM), os quais 
antagonizam selectivamente os receptores P2Y1, P2Y12 e P2Y13, 
respectivamente. O efeito facilitatório induzido pelo ADPβS (100 µM) foi 
atenuado de forma significativa na presença do antagonista dos receptores 
P2Y1, o MRS 2179 (0.3 µM, n=3), sem ser afectado pelo antagonista dos 
receptores P2Y12, o AR- C 66096 (0.1 µM, n=3). Pelo contrário, o MRS 2211 
(10 µM, n=2) potenciou o aumento da produção de colagénio induzida pelo 
ADPβS (100 µM), indicando assim que a síntese de colagénio tipo I induzida 
pelo receptor P2Y1 pode estar a ser parcialmente influenciada por uma 
activação síncrona do receptor inibitório P2Y13. Por último, uma análise por 
imunocitoquímica mostrou que estas células apresentam imunorreactividade 
positiva para os receptores P2Y1 e P2Y13, exibindo um padrão 
citoplasmático/membranar, contrariamente ao padrão nuclear dos receptores 
ostentado pelo anticorpo contra os receptores P2Y12.  
Concluindo, a remodelação da fáscia superficial induzida pelos fibroblastos 
parece ser regulada por um balanço entre a activação dos receptores P2Y2 e 
P2Y6, assim como dos receptores P2Y13 e P2Y1. Clarificar as vias que 
conduzem ao processo de fibrose pode representar uma oportunidade para 
esclarecer o seu envolvimento na patogénese da dor crónica musculo-
esquelética, bem como ser útil no desenvolvimento de novas estratégias 
terapêuticas. 
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abstract 
 
Connective tissue may be involved in the pathogenesis of a wide variety of 
disease conditions. Increased connective tissue stiffness due to fibrosis may be 
an important link to the pathogenic mechanism leading to drug-resistant chronic 
pain (Langevin & Sherman, 2007). In addition, extracellular nucleotides seem 
to be involved in the pathophysiology of chronic pain (Burnstock, 2001). 
Therefore, we aimed at investigating the effect of adenine and uridine 
nucleotides on the proliferation and synthesis of type I collagen by rat 
fibroblasts from subcutaneous connective tissue.  
The results showed that continuous incubation of UTP (0.3-100 M, n=5) 
concentration-dependently increased fibroblasts proliferation, as also increased 
the synthesis of type I collagen above the control levels. Conversely, the 
selective P2Y2 agonist, MRS 2768 (10 µM, n=3), was devoid of effect in what 
concerns proliferation, but significantly (P<0.05) decreased type I collagen 
synthesis. Since the increase in type I collagen synthesis induced by UTP (100 
µM) was proportional to the increase in the amount of cells in the culture 
(fibroblasts proliferation), we speculated that such an increase could be related 
to the increase in the cell number rather than a higher synthetic activity. Thus, 
we performed a more detailed data analysis, in which we normalized type I 
collagen production taking into consideration the MTT values obtained at the 
same time points, and we observed no longer significant differences between 
control and UTP-exposed cells. 
Discounting the contribution of MRS 2768-sensitive P2Y2 receptors, UTP (100 
µM)-induced increase in cells proliferation could be due to P2Y4 and/or P2Y6 
receptor activation. Since RB-2 (10 µM, n=5), a non-selective antagonist that 
acts preferentially on the P2Y4 subtype, did not modify the effect of UTP (100 
µM), P2Y4 does not seem to be involved. In turn, MRS 2578 (100 nM), which is 
a selective P2Y6 antagonist, significantly attenuated UTP (100 µM)-induced 
increase.  
To corroborate our results, an immunocytochemistry analysis showed a 
positive immunoreactivity against the P2Y2 and P2Y6 receptors exhibiting a 
cytoplasmic/membrane labeling pattern, which is typical for those receptors in 
many different cells, conversely to the nuclear labeling pattern exhibited by the 
antibody against the P2Y4.  
To investigate the involvement of ADP-sensitive P2 receptors on cell 
proliferation and extracellular matrix production, fibroblast cultures were 
continuously incubated with the stable ADP analogue, ADPβS (10-100 µM). 
Results obtained with ADPβS (10-100 µM, n=3-6) showed no significant 
(P>0.05) differences in fibroblast cells proliferation. However, a continuous 
incubation with ADPβS (10-100 µM, n=2-5) concentration-dependently 
increased type I collagen production by fibroblasts (P<0.05). In order to identify 
which purinoceptor(s) that could be mediating this effect, we tested ADPβS 
(100 µM) in the presence of MRS 2179 (0.3 µM), AR-C 66096 (0.1 µM), and 
MRS 2211 (10 µM), which antagonize selectively ADP-sensitive P2Y1, P2Y12 
and P2Y13 receptors, respectively. The facilitatory effect of ADPβS (100 µM) 
was significantly attenuated in the presence of the P2Y1 antagonist, MRS 2179 
(0.3 µM, n=3), without being affected by the P2Y12 antagonist, AR- C 66096 
(0.1 µM, n=3). In contrast, MRS 2211 (10 µM, n=2) potentiated the effect of 
ADPβS (100 µM) on type I collagen synthesis, thus indicating that the P2Y1-
receptor-induction of type I collagen synthesis may be partially counteracted by 
synchronous activation of the inhibitory P2Y13 receptor. Finally, an 
immunocytochemistry analysis showed that these cells exhibit immunoreactivity 
to P2Y1 and P2Y13 receptors with a cytoplasmic/membrane staining pattern, 
conversely to the nuclear pattern of P2Y12.  
Concluding, a delicate balance between the activation of P2Y2 and P2Y6, as 
well as P2Y13 and P2Y1 purinoceptors, might regulate fibroblast’s induced 
superficial fascia remodeling. Targeting the pathways leading to fibrosis may 
represent an opportunity to clarify its involvement in the pathogenesis of 
musculoskeletal chronic pain and it may be useful for designing novel 
therapeutic strategies to overcome this disease. 
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List of symbols and abbreviations 
 
ADP Adenosine 5’-diphosphate sodium salt 
ADPβS Adenosine 5′-[β-thio]diphosphate trilithium salt 
AMP Adenosine 5’-monophosphate sodium salt 
Apyrase NTPDase 1 or nucleotide diphosphohydrolase  
ATP Adenosine 5’-triphosphate disodium salt 
AR-C 66096 2-(Propylthio)adenosine-5'-O-(β,γ-difluoromethylene)triphosphate tetrasodium salt 
BSA Bovine serum albumin 
cAMP Cyclic adenosine 5’-monophosphate 
Ca2+ Calcium ion 
DMEM Dulbecco’s Modified Eagle’s Medium 
DMSO Dimethyl sulfoxide 
DRG Dorsal root ganglion 
ECM Extracellular matrix 
EP Prostaglandin E receptors 
ER Endoplasmic reticulum 
FBS Fetal bovine serum 
FMS Fibromyalgia syndrome 
GPCR G-protein coupled receptor 
K+ Potassium ion 
MTP Myofascial trigger points 
MP Myofascial pain 
MRS 2179 2'-Deoxy-N6-methyladenosine 3',5'-bisphosphate tetrasodium salt 
MRS 2211 2-[(2-Chloro-5-nitrophenyl)azo]-5-hydroxy-6-methyl-3-[(phosphonooxy)methyl]-4-
pyridinecarboxaldehyde disodium salt 
MRS 2365 [[(1R,2R,3S,4R,5S)-4-[6-Amino-2-(methylthio)-9H-purin-9-yl]-2,3-dihydroxybicyclo[3.1.0]hex-
1-yl]methyl] diphosphoric acid mono ester trisodium salt 
MRS 2578 N,N''-1,4-Butanediylbis[N'-(3-isothiocyanatophenyl)thiourea] 
MRS 2768 Uridine-5'-tetraphosphate δ-phenyl ester tetrasodium salt 
Na+ Sodium ion 
PBS Phosphate Buffered Saline 
PKA Protein kinase A 
PKC Protein kinase C 
PLA2 Phospholipase A2 
PLC Phospholipase C 
RER Rough endoplasmic reticulum 
RB-2 Reactive blue-2 
TG Trigeminal ganglion 
UDP Uridine 5′-(trihydrogen diphosphate) sodium salt 
UTP Uridine 5′-triphosphate trisodium salt 
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1. Introduction 
 
1.1 Pain associated with connective tissue 
 
Chronic pain is a major health care problem that occurs in 19% of the adult Europeans, seriously 
affecting the quality of their social and working lives (Breivik et al., 2006). Myofascial pain represents the 
most common cause of chronic pain, including neck and shoulder pain, tension headaches, and lower 
back pain (Granges et al., 1993). It can be associated with other neuromusculoskeletal disorders and 
can be perpetuated or aggravated by conditions such as mechanical stress, metabolic inadequacies, or 
psychological factors (Hong & Simons, 1998). In fact, in many chronic pain states the causal relationship 
between nociception and pain is not tight and the pain does not reflect tissue damage. Rather, 
psychological and social factors seem to determine the pain, as well it may be accompanied by 
neuroendocrine dysregulation, fatigue, dysphoria, and impaired physical and even mental performance 
(reviewed by Schaible & Richter, 2004).  
Similar to the fibromyalgia syndrome (FMS), myofascial pain has been defined as a pain 
syndrome associated with myofascial trigger points (MTP) (Granges et al.,1993), which are 
characterized as highly localized and hyperirritable spots in a palpable taut band of skeletal muscle 
fibers (Hong & Simons, 1998). Although it is unclear whether MTP are the cause or effect of muscle 
injury, they represent abnormally contracted muscle fibers. This muscle contraction can lead to the 
accumulation of signaling molecules that are essential to the onset and maintenance of inflammatory 
reactions, like prostaglandins, bradykinin, histamine, ATP and serotonin, and others (Staud, 2004), 
which can ultimately influence nociceptors activity.  
Nociceptors are free nerve endings of sensory neurones distributed throughout the body. When 
activated by noxious stimuli, they are responsible to generate impulses along afferent nerves to the 
central nervous system resulting in the perception and consciousness of pain (see Fig. 1). Most of the 
nociceptors are polymodal, responding to noxious mechanical, thermal and chemical stimuli, and there 
are mainly two types of nociceptors: slow non-myelinated C-fibres, that convey chemical, heat and 
pressure noxious information; and rapid myelinated A-fibres, which conduct heat and mechanical 
noxious stimuli (reviewed by Markenson, 1996; reviewed by Pleuvry & Lauretti, 1996). In normal tissue, 
sensory neurons have relatively high mechanical and thermal thresholds, and high intensity stimuli are 
required to excite them. However, during inflammation the excitation threshold drops and polymodal 
nociceptors become sensitized, such that even light, normally innocuous stimuli activate the fibres. Thus, 
when sensitized “pain fibres” are activated by normally non-painful stimuli these stimuli cause pain and 
noxious stimuli evoke even stronger responses than in the non-sensitized state. In addition, inflammation 
induces also the recruitment of the so-called silent nociceptors. These are C-fibres that are inexcitable 
by noxious mechanical or thermal stimuli in normal tissue. However, during inflammation these primarily 
mechanosensitive fibres are sensitized, and then they are activated by stimuli. Both the enhanced 
activity of sensitized polymodal nociceptors and the recruitment of silent nociceptors generate the 
pathophysiological nociceptive input to the spinal cord (reviewed by Schaible & Richter, 2004). 
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Figure. 1. Scheme of the nociceptive system with nociceptive free nerve endings in the peripheral tissue, afferent 
nerve fibres and their synapses in the dorsal horn of the spinal cord. From there, the medial and lateral 
spinothalamic tracts ascend to the medial and lateral thalamus. Ascending axons in the spinothalamic tract activate 
the thalamocortical system that produces the conscious pain sensation. The pain sensation has a sensory 
discriminative aspect, i.e. the noxious stimulus is analysed for its location, duration and intensity. This is produced 
in the lateral thalamocortical system, which consists of relay nuclei in the lateral thalamus and the areas SI and SII 
in the postcentral gyrus. A second component of the pain sensation is the affective aspect, i.e. the noxious stimulus 
feels unpleasant and causes aversive reactions. This component is produced in the medial thalamocortical system, 
which consists of relay nuclei in the central and medial thalamus and the anterior cingulate cortex (ACC), the 
insula, and the prefrontal cortex (from Schaible & Richter, 2004). 
 
A recent hypothesis refers that increased connective tissue stiffness due to fibrosis may be an 
important link to the pathogenic mechanism leading to chronicity of pain (Langevin & Sherman, 2007). 
Certain conditions, like excess of mechanical stress, inflammation or immobility can result in excessive 
and disorganized collagen and matrix deposition resulting in fibrosis and adhesions (Liptan, 2009), which 
subsequently implies an increase of the tension to the adjacent tissues. Considering that similar to skin, 
the adjacent subcutaneous connective tissue is richly innervated by sensory nerve endings, including 
nociceptors (Willis & Coggeshall, 1991), sensory input arising from affected connective tissue may be 
altered, contributing to the modulation of nociceptors activity.  
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1.2 Subcutaneous connective tissue (superficial fascia) 
 
Connective tissue is derived from the mesodermis and may originate specialized tissues, such as 
bone, cartilage, and others. The term fascia has long been used by gross anatomists to embrace several 
undifferentiated mesenchymal tissues that wrap around what are sometimes regarded as being the more 
‘specialized’ organs and tissues of the body. This traditional idea has the inherent and wrong implication 
that fascia consists on less important supporting tissues. Increasingly, the errors of this assumption are 
being exposed and undoubtedly fascia is of considerable importance to many professionals working in 
health-related professions, like surgeons, physiotherapists, and others (reviewed by Abu-Hijleh et al., 
2006).  
According to its location and characteristics, fascia is classified into superficial and deep fascia. 
The superficial fascia, also called subcutaneous tissue, is traditionally regarded as a layer of areolar 
connective and adipose tissue immediately beneath the skin (Fig. 2A), whereas deep fascia is a tougher, 
dense connective tissue continuous with it (reviewed by Abu-Hijleh et al., 2006) (Fig. 2B).  
 
 
Figue 2. (A) Schematic representation of the superficial fascial system between the skin and the underlying 
muscles (by Dr J. C. Guimberteau). (B). Dissection of teased muscle fibers, showing surrounding and investing 
endomysial fascia (original image from Ronald Thompson). Both images were obtained on Myers, 2009.  
 
Despite its overwhelming relative size and import, superficial fascia has been heretofore 
generally overlooked or misunderstood as relatively superfluous by conventional dissection methods. 
However, it has its own nervous, vascular and lymphatic endowment, its own complex, elastic and 
resilient connective tissue matrix, and abundant fatty deposition, which are properties of a discreet and 
vital organ. In consideration of its demonstrable unity and integrity seen in Fig. 3, the structural, 
physiological and energetic properties and functions of superficial fascia, recognized both as a discreet 
and ubiquitous human organ, as well as in relation to other types of fascia, require further study (Hedley, 
2008). 
 
A B 
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Figure 3. Dissection of the superficial fascia of a female cadaver, demonstrating a continuous, whole body tissue 
layer (hands, feet and head/neck were excluded) (Hedley, 2008). 
 
 
1.2.1. Extracellular matrix (ECM) 
 
Fascia is mainly formed by extracellular matrix (ECM) and several different cells, including 
fibroblasts, macrophages and mast cells (Fig. 4). The ECM is composed of ground substance and fibers 
of collagen, elastin and reticulin (Liptan, 2010).   
Reticulin is a very fine fiber, a kind of immature collagen that predominates in the embryo but is 
largely replaced by collagen in the adult (Myers, 2009). Elastin is synthesized by fibroblasts in a 
precursor form known as tropoelastin which undergoes polymerization in the extracellular tissue and 
confers the properties of stretching and elastic coil (Young et al., 2000). Collagen, by far the most 
common protein in the body, predominates in the fascial net, mainly type I collagen. These fibers are 
composed of amino acids that are assembled in the endoplasmic reticulum and Golgi complex of the 
fibroblast and then extruded into the intercellular space (Myers, 2009).  
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Figure 4. Schematic representation of the connective tissue constitutive elements, namely cells, fibers, and 
interfibrillar ground substance (proteoaminoglycans) (Williams, 1995.) 
 
The ground substance is a watery gel composed of mucopolysaccharides or glycosaminoglycans 
such as hyaluronic acid, chondroitin sulfate, keratin sulfate, and heparin sulfate. These fern-like colloids, 
which are part of the environment of nearly every living cell, bind water in such a way as to allow the 
easy distribution of metabolites (at least, when the colloids are sufficiently hydrated), and form part of the 
immune system barrier, being very resistant to the spread of bacteria. Produced by the fibroblasts and 
mast cells, this proteoglycan forms a continuous but highly variable 'glue' to help the trillions of tiny 
droplets of cells both hold together and yet be free to exchange the myriad substances necessary for 
living. In an active area of the body, the ground substance changes its state constantly to meet local 
needs; in a 'held' or 'still' area of the body, it tends to dehydrate to become more viscous, more gel-like, 
and to become a repository for metabolites and toxins (Myers, 2009). The size of the spaces between 
the glycosaminoglycans molecules and the nature of electrostatic changes determines the permeability 
characteristics of the tissue, a fact of particular significance in the structure of basement membranes and 
mechanical properties of ground substance that are reinforced by the fibrous proteins (Young et 
al.,2000). 
 
 
1.2.2. Fibroblasts 
 
Fibroblasts are the predominant cell type of superficial fascia. In general, fibroblasts may occur in 
either an active or a quiescent state. Some histologists differentiate between them, calling the quiescent 
cells fibrocytes. Active fibroblasts often reside in close proximity to collagen fibers, which lie parallel to 
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the axis of the fiber. Such fibroblasts are typically elongated and fusiform cells, possessing a pale-
staining cytoplasm and a darker-stained, large, granular, ovoid nucleus containing well-defined 
nucleolus. By electron microscopy it is also observed a proeminent Golgi apparatus and an abundant 
rough endoplasmic reticulum (RER), especially when the cell is actively manufacturing matrix, as in 
wound healing. Actin and α-actin are localized at the periphery of the cell, whereas myosin is present 
throughout the cytoplasm. In contrast, inactive fibroblasts are smaller, more ovoid, and possess an 
acidophilic cytoplasm. Their nucleous are smaller, elongated, and more deeply stained and electron 
microcopy reveals sparse amounts of RER but an abundance of free ribosomes (Gartner & Hiatt, 2007).  
Connective tissue fibroblasts are typically represented in histology textbooks as discrete fusiform 
or stellate cells with varying numbers of irregular cytoplasmic processes that suggest the fibroblasts are 
not separate cells, but rather are linked together in a reticular network extending throughout the whole 
body (Langevin et al., 2004). They are responsible for the synthesis of collagen, elastic and reticular 
fibers, and the complex carbohydrates of the ground substance. Indeed, research suggests that a single 
fibroblast is capable of producing all of the ECM components (Ross et al., 2010), but they are also an 
important source of ECM degrading proteases, and have a crucial role in maintaining homeostasis and 
repair in the ECM (Kalluri & Zeisberg, 2006). When ECM material is produced during active growth or in 
wound repair (in activated fibroblasts), the cytoplasm of the fibroblasts is more extensive and may 
display basophilia as a result of increased amounts of RER associated with protein synthesis (Ross et 
al., 2010). Fibroblast activation is induced by various stimuli that occur with tissue injury (Kalluri & 
Zeisberg, 2006). Activated fibroblasts isolated from the site of a healing wound will continue to secrete 
higher levels of extracellular matrix and proliferate more rapidly than fibroblasts obtained from normal 
tissue (Liptan, 2009). 
 
 
1.3. Subcutaneous tissue response to injury or insults 
 
The response of connective tissue to injury occurs mainly in three phases: (1) the inflammatory 
phase, which is characterized by invasion of polymorphonuclear cells and monocytes/macrophages, and 
the release of prostaglandin and cytokines; (2) the proliferative phase, in which fibroblasts are activated 
to produce ECM; and (3) the remodeling phase, when occurs a progressive maturation and alignment of 
collagen fibers and remodeling of the ECM previously produced (Liptan, 2009).  
Skin fibroblasts are generally quiescent but they become rapidly activated after cutaneous 
wounding. Activated fibroblasts migrate to the fibronectin-fibrin wound interface, proliferate, and 
synthesize a new collagen containing matrix called granulation tissue. Once the wound defect is 
replaced, the expanded fibroblast population stops dividing and extracellular matrix remodeling 
commences. Gene expression and proliferation of these cells is regulated by mechanical force, the 
mechanotransducers and signaling mechanisms (reviewed by Grinnel et al., 1994). Furthermore, dermal 
fibroblasts and fibroblast-like cells are in a close contact with sensory nerve terminals, which release 
signaling substances that may affect fibroblasts under physiological or pathological conditions. In fact, 
successful healing of wounds requires sensory innervation and the release of vasoactive neuropeptides 
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that dilate blood vessels and deliver serum proteins to the wound so as to prevent further injury (Zeng et 
al., 2009). 
Besides a distinct injury or lesion, both increased stress due to overuse, repetitive movement 
and/or hypermobility, and decreased stress due to immobilization or hypomobility are able to induce 
changes and a reorganization of the connective tissue (Cummings et al., 1992; Vidman, 1987). A 
chronic, local increase in stress can lead to microinjury and inflammation (Carpenter et al., 1998; Perry 
et al., 2005), and a consistent absence of stress, on the other hand, leads to connective tissue atrophy, 
architectural disorganization, fibrosis, adhesions and contractures.  
The phenomena of myofascial trigger points (MTP), mentioned before, may also contribute to 
connective tissue remodeling and fibrosis. Although there is some controversy as to the definition and 
nature (Hong et al., 1998; Bohr et al., 1996), decreased tissue pH and increased levels of inflammatory 
cytokines were recently reported in MTP and associated to the presence of pain (Shah et al., 2005). 
Thus, the presence of painful muscle contraction within perimuscular fascia may be related to factors 
promoting hypomobility and tissue fibrosis. For example, in the fibromyalgia syndrome fibroblasts 
respond to chronic excess fascial tension overproducing ECM in a continuous attempt to fight to the 
increased mechanical stress (Liptan, 2009). Regardless of its original cause, connective tissue fibrosis is 
detrimental, as it leads to increased tissue stiffness and further movement impairment, which may 
contribute to its neighboring cells dysfunction.  
In addition, since this web of tissue is populated by an interconnected network of fibroblasts that 
rapidly respond to tissue stretch (within minutes) with active, dynamic, and reversible changes in cell 
shape (Langevin et al., 2006), superficial connective tissue may have considerable significance as it may 
support yet unknown body-wide cellular signaling systems (Langevin et al., 2004). 
 
 
1.4. Purinergic receptors and pain 
 
There were early hints that ATP might be involved in pain from different origin sources. In fact, 
ATP has been claimed to excite or sensitize myofascial nociceptors, being related to myofascial pain. 
Infusing a combination of ATP, serotonin, histamine, and prostaglandins in human muscle induced 
prolonged muscle pain and tenderness. Furthermore, ATP induces sustained facilitation of nociception 
through P2X receptors on neck muscle nociceptors in mice.  In 1996, Burnstock hypothesized that 
initiation of pain implies the activation of purinoceptors localized on dorsal root ganglia neurones, due to 
the release of ATP from several different cells (Fig. 5). This hypothesis has been increasingly reinforced 
by more recent evidence. There is strong enhancement of nociception produced via P2X3 and P2X2/3 
receptors in rat hindpaw by noradrenaline and serotonin. Also prostaglandin E2, an inflammatory 
mediator, potentiates P2X3 receptor-mediated responses in DRG neurons (reviewed by Burnstock, 
2007).  
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Figure 5. Hypothetical scheme of the roles of purine nucleotides and nucleosides in pain pathways. At sensory 
nerve terminals in the periphery, P2X3 and P2X2/3 receptors have been identified as the principal P2X 
purinoceptors present, although recent studies have also shown expression of P2Y1 and possibly P2Y2 receptors. 
Other known P2X purinoceptor subtypes (1–7) are also expressed at low levels in dorsal root ganglia. Although 
less potent than ATP, adenosine (AD) also appears to act on sensory terminals, probably directly via P1 (A2) 
purinoceptors; however, it also acts synergistically to potentiate P2X2/3 receptor activation, which also may be true 
for 5-hydroxytryptamine, capsaicin, and protons. P2X3 receptors on the central projections of primary afferent 
neurons in lamina II of the dorsal horn mediate facilitation of glutamate and probably also ATP release. Sources of 
ATP acting on P2X3 and P2X2/3 receptors on sensory terminals include sympathetic nerves as well as endothelial, 
Merkel, and tumor cells (Burnstock, 2007). 
 
Conversely, Burnstock (2009) also hypothesized that the mechanism underlying pain relief 
induced by acupuncture might be due to the release of ATP. It was proposed that mechanical 
deformation of the skin by needles and application of heat or electrical current leads to the release of 
large amounts of ATP from keratinocytes, fibroblasts and other cells. ATP would then excite specific 
receptor subtypes expressed on sensory nerve endings, which send impulses through ganglia to the 
spinal cord, brain stem, hypothalamus and higher centres. Impulses generated in sensory fibres connect 
with interneurons to modulate (either inhibition or facilitation) the activities of the motoneurons in the 
brain stem and hypothalamus to change autonomic functions; specifically activated sensory nerves, via 
interneurons, also inhibit the neural pathways to the pain centres in the cortex (Burnstock, 2009).  
Thus, the mechanism(s) by which purinergic signals underlie myofascial pain are still a matter of 
speculation. 
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1.5. Purinergic involvement in fibrosis 
 
Extracellular nucleotides have been implicated in a wide range of biological processes, including 
cell migration, proliferation, differentiation and extracellular matrix production (Braun et al., 2010; Costa 
et al., 2011; Noronha-Matos et al., 2011). A previous study has shown that UTP promoted a transient 
profibrotic response in cardiac fibroblasts (Braun et al., 2010). Also in cardiac fibroblasts, it has been 
demonstrated that adenosine, via activation of A2B receptors, inhibited the production of collagen and 
total protein, which seems to have a protective effect on the development of cardiac fibrosis (Dubey et 
al., 1998). However, a comprehensive study on the physiological significance of adenine and uridine 
nucleotides in the musculoskeletal system, namely superficial fascia, is still lacking. A better 
understanding of fibroblasts’ signalling mechanisms related to extracellular purines may represent an 
opportunity to clarify their involvement in the pathogenesis of fibrosis and musculoskeletal chronic pain. 
 
 
 
 
 
1.6. Purinoceptors 
 
Extracellular purines (adenosine, ADP, and ATP) and pyrimidines (UDP and UTP) are important 
signaling molecules that mediate diverse biological effects via cell surface receptors termed 
purinoceptors (Ralevic et al., 2008).  
  “Purinergic” receptors were first formally recognized by Burnstock in 1978, when he proposed 
that these can be divided into two classes termed “P1-purinoceptors”, at which adenosine is the principal 
natural ligand, and “P2-purinoceptors”, recognizing ATP and ADP (Ralevic et al., 2008). 
 
1.6.1 P1 receptors: structure and biochemical response 
 
Considering molecular, biochemical and pharmacological studies, the adenosine/P1 receptors 
were divided into four subtypes, A1, A2A, A2B, and A3. All of these receptors are couple to G proteins and 
have seven putative transmembrane (TM) domains of hydrophobic amino acids, each believed to 
constitute an α-helix of approximately 21 to 28 amino acids. The N-terminal of the protein lies on the 
extracellular side and the C-terminal on the cytoplasmic side of the membrane. A pocket for the ligand 
binding site is formed by the three-dimensional arrangement of the α -helical TM domains, and the 
agonist is believed to bind within the upper half of this pore. The transmembrane domains are connected 
by three extracellular and three cytoplasmic hydrophilic loops of unequal size; typically the extracellular 
loop between TM4 and TM5 and the cytoplasmic loop between TM5 and TM6 is extended (Fig. 6) 
(reviewed by Ralevic & Burnstock, 1998). 
The P1 receptors are mainly coupled to adenylate cyclase: A1 and A3 are negatively coupled to 
adenylate cyclase through the Gi/o protein α-subunits, whereas A2A and A2B are positively coupled to 
adenylate cyclase through Gs. The human A2B receptor has also been observed to couple through Gq/11 
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to regulate phospholipase C activity, and the A3 receptor may interact directly with Gs (reviewed by 
Burnstock, 2007). 
 
 
 
Figure 6. The P1 family of receptors for extracellular adenosine are G protein-coupled receptors (S-S; disulfide 
bond) (by Ralevic & Burnstock, 1998). Image obtained on Burnstock, 2007. 
 
 
1.6.2  P2 receptors: structure and biochemical response 
 
Based on differences in molecular structure and signal transduction mechanisms, P2 receptors 
were divided into two families: (1) the ionotropic P2X receptors, which are ligand-gated ion channels 
(Fig. 7A); and (2) the metabotropic P2Y receptors, that are coupled to a G protein (Fig. 7B). To date, 
seven mammalian P2X receptors (P2X1–7) and eight mammalian P2Y receptors (P2Y1, P2Y2, P2Y4, 
P2Y6, P2Y11, P2Y12, P2Y13 and P2Y14) have been cloned, characterized, and accepted as valid members 
of the P2 receptor family (Ralevic & Burnstock, 1998). 
The ionotropic P2X receptors are characterized by an intracellular N- and C-termini, two 
transmembrane spanning regions (TM1 and TM2, the first involved with the channel gating and the 
second lining to the ion pore), and a large extracellular loop, with 10 conserved cysteine residues 
forming a series of disulphide bridges and an ATP-binding site, which may involve regions of the 
extracellular loop adjacent to TM1 and TM2. The P2X1-7 receptors show 30-50% sequence identity at 
the amino acid level. The stoichiometry of those receptors is thought to involve three subunits, which 
form a trimer. Heteromultimers as well as homomultimers are involved in forming the trimer ion pore. 
Heteromultimers are clearly established for P2X2/3 receptors in nodose ganglia, P2X4/6 vessels, 
P2X2/6 receptors in the brain stem and more recently P2X1/4 and P2X1/2 receptors. P2X7 receptors do 
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not form heteromultimers, and P2X6 receptors will not form a functional homomultimer (Burnstock, 
2006). 
 
 
Figure 7. Membrane receptors for extracellular ATP. ADP, UTP and UDP. (A) The P2X family of receptors are 
ligand-gated ion channels (S-S; disulfide bond; M1 and M2, transmembrane domains) (by Brake et al., 1994). (B). 
The P2Y family of receptors are G protein-coupled receptors (S-S; disulfide bond) (by Barnard et al. 1994). Both 
images were obtained from Burnstock, 2007. 
 
 
Metabotropic P2Y receptors are characterized by: an extracellular N-terminus and an intracellular 
C-terminus; seven transmembrane spanning regions; a high level of sequence homology between some 
transmembrane spanning regions; a structural diversity of intracellular loops; and a C-terminus among 
P2Y subtypes, thus influencing the degree of coupling with Gq/11, Gs and Gi proteins. Each P2Y receptor 
binds to a single heterotrimeric G protein (typically Gq/11), although P2Y11 can couple to both Gq/11 and 
Gs, whereas P2Y12,13,14 couple to Gi. P2Y receptors may form homo- and heteromultimeric assemblies 
under some conditions, and many cells express multiple P2Y receptor subtypes (fig.4). Some P2Y 
receptors are activated principally by nucleotide diphosphates (P2Y1,6,12,13), while others are activated 
mainly by nucleotide triphosphates (P2Y2,4). Some P2Y receptors are activated by both purine and 
pyrimidine nucleotides (P2Y2,4,6), and others by purine nucleotides only (P2Y1,11,12,13). In response to 
nucleotide activation, recombinant P2Y receptors either activate phospholipase C and release 
intracellular calcium or affect adenylyl cyclase and alter cAMP levels (Burnstock, 2006).  
 
 
1.7. Nucleotides release to the extracellular millieu  
 
The release of endogenous nucleotides represents a critical component for initiating a signalling 
cascade. A massive leakage of nucleotides might occur upon cell lysis, however this is a nonspecific 
mechanism restricted to damaged tissue. Non-lytic mechanisms of nucleotide efflux represent a distinct 
and important route of nucleotide appearance in the extracellular milieu. The diversity of conditions in 
A B 
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which the cells release nucleotides (such as ATP, ADP, UTP and/or UDP) suggests the implication of 
multiple nucleotide-releasing pathways. The proposed cellular mechanisms might include: (1) 
electrodiffusional movement through membrane ion channels, including connexin hemichannels; (2) 
facilitated diffusion by nucleotide-specific ATP-binding cassette (ABC) transporters; and (3) cargo-vesicle 
trafficking and exocytotic granule secretion (Fig. 8) (reviewed by Yegutkin, 2008). 
 
 
Figure 8. Nucleotide-releasing pathways. Along with massive nucleotide leakage upon cell damage, nucleotides 
can appear in the external milieu via various non-lytic pathways, including electrodiffusional movement through 
ATP release channels, facilitated diffusion by nucleotide-specific transporters and vesicular exocytosis (Yegutkin, 
2008). 
Several different types of cells have been shown to release ATP transiently under various 
mechanical and other stimuli, such as shear stress, hypotonic swelling, hypoxia, stretching, hydrostatic 
pressure, as well as in response to bradykinin, serotonin and other Ca2+-mobilizing pharmacological 
agonists. Moreover, the cells release low nanomolar concentrations of ATP at certain basal rates and 
distinctive mechanisms could underlie constitutive versus stress-stimulated nucleotide release (reviewed 
by Yegutkin, 2008).  
 
 
1.8. Fibroblast cells culture 
 
Cell culture has become one of the major tools used in the life sciences in our days. Cell culture 
refers to cultures derived from dispersed cells taken from the original tissue, from a primary culture, or 
from a cell line or cell strain by enzymatic, mechanical, or chemical disaggregation (Freshney, 2000).  
Primary culture cells are directly obtained from a specific fragment of the organism, which is 
placed into a suitable culture environment. There are two basic methods to obtain primary cultures, 
namely explantation and enzymatic dissociation. To perform the explant technique, small pieces of 
tissue are cut and allowed to attach to the culture dish surface. A few days after, cells start to migrate 
and proliferate. The disadvantages of this technique rely on the poor adhesiveness of some tissues and 
the selection of cells in the outgrowth, since cells need to be able to migrate. The enzymatic dissociation 
involves a proteolytic process, generally by adding enzymes such as trypsin or collagenase, which 
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disrupt cell-cell adhesion and the extracellular matrix, creating a suspension of single cells. Although the 
last method is widely used, enzymatic disaggregation selects the more resistant cells (Freshney, 2000).  
Fibroblasts can be obtained from a connective tissue fragment. These cells are very resilient, 
surviving to the most enzymatic dissociation and explantation techniques. The maintenance of 
fibroblasts in culture may be easily reached using simple medias, such as Eagle’s basal medium 
(Freshney, 2000).  
Depending on the original tissue, primary cultures are usually heterogeneous and have a variable 
growth fraction. Once a primary culture is subcultured, a more homogeneous cell culture emerges, which 
is important for the reproducibility of experiments and results (Freshney, 2000). 
 
 
1.9. Cell proliferation and extracellular matrix production 
 
Generally, differentiated cells in a tissue have limited ability to proliferate. Therefore, 
differentiated cells do not contribute to the formation of a primary culture, unless special conditions are 
used to promote their attachment and preserve their differentiated status. It is the proliferating committed 
precursor, such as fibroblasts, that usually gives rise to the bulk of the cells in a primary culture, as, 
numerically, these cells represent the largest proliferating, or potentially proliferating, cells (Freshney, 
2006b).  
Cell proliferation and the characterization of agents that either promote or retard cell proliferation 
are extremely important areas of cell biology research. Most cell proliferation assays estimate the 
number of cells either by incorporating a modified nucleotide into cells during proliferation or by 
measuring total nucleic acid or protein content of lysed cells. For simply detecting the presence or 
counting the number of cells, fluorescent stains that identify cells by their characteristic morphology or 
light-scattering properties may be sufficient. However, the MTT cell proliferation assay simplifies the task 
of counting cells with a microplate absorbance reader. The colorimetric MTT assay, developed by 
Mosmann (1983), is based on the conversion of the water-soluble MTT to an insoluble purple formazan. 
This formazan is then solubilized, and its concentration determined by optical density at 600 nm. The 
assay detects living, but not dead cells and the signal generated is dependent on the degree of 
activation of the cells. This method can therefore be used to measure cytotoxicity, proliferation or 
activation. The results can be read on a multiwell scanning spectrophotometer (ELISA reader) and show 
a high degree of precision. The main advantages of the colorimetric assay are its celerity and precision, 
and the lack of any radioisotope (Mossman, 1983; Berridge et al., 1993). These characteristics turned 
the MTT assay a very widely used method (Ciapetti et al., 1993; Kilger et al., 1998; Lucarellia et al., 
2003; Costa et al., 2011; Noronha-Matos et al., 2011).  
Once fibroblasts from subcutaneous connective tissue play a relevant role in ECM production, 
including type I collagen synthesis, which represents the majority of the extracellular proteins, 
quantification of type I collagen should be considered. Although the quantitative determination of 
collagen content in cells is usually based on the measurement of its hydroxyproline content by chemical 
methods or by the incorporation of radioactively labeled proline into collagens, which allows to quantify 
the rate of collagen synthesis and degradation, the specific staining of collagen with Sirius Supra Red is 
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a standard procedure which has been used in histology for many years (Sweat et al. 1964). Sirius Red is 
an elongated molecule containing six sulphonic acid groups. As collagen is a basic protein, the sulphonic 
groups of the dye interact at a low pH with the amino groups of lysine and hydroxylysine, and the 
guanidine groups of arginine. Since the elongated dye molecules attach to the collagen fibre in such a 
way that their long axes are parallel, the relationship between dye and collagen results in an enhanced 
birefringency that can be measured in a spectrophotometer at 550 nm (Junqueira et al., 1979). 
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2. Aims 
 
As mentioned before, connective tissue may be involved in the pathogenesis of a wide variety of 
disease conditions. Increased connective tissue stiffness due to fibrosis may be an important link to the 
pathogenic mechanism leading to drug-resistant chronic pain (Langevin & Sherman, 2007). In addition, 
extracellular nucleotides seem to be involved in the pathophysiology of chronic pain. Fibroblasts, the 
predominant cell constituent of the connective tissue, are able to release nucleotides in response to 
stressful conditions, like mechanical stimuli and inflammatory mediators. Furthermore, once released, 
ATP/UTP may be rapidly terminated by a cell-surface bound enzymatic cascade (ectoNTPDases) that 
sequentially degrades ATP/UTP and ADP/UDP to AMP/UMP and, subsequently, to adenosine/uridine, 
respectively, which can all appear in the extracellular fluid at the same time (Zimmermann, 1996; 
Yegutkin, 2008). Thus, depending on the extracellular metabolism of nucleotides by these cells and on 
the purinergic receptors expression, proliferation and collagen production may be influenced by several 
biologically-active mediators acting via nucleotide-sensitive P2 and/or nucleoside-sensitive P1 receptors.  
Preliminar results from our group suggest that rat fibroblasts of the subcutaneous connective 
tissue respond to adenine and uridine nucleotides by increasing intracellular [Ca2+]i oscillations through 
the activation of subtype-selective P2Y purinoceptors (Certal et al., 2011). While these findings support 
the expression of P2 purinoceptors in these cells, their roles in the proliferation and extracellular matrix 
remodeling in subcutaneous tissue have yet to be elucidated. Therefore, we aimed at investigating the 
effect of adenine and uridine nucleotides in the proliferation and synthesis of type I collagen by rat 
fibroblasts from subcutaneous connective tissue. A better understanding of fibroblasts’ signaling 
mechanisms related to extracellular purines may represent an opportunity to clarify their involvement in 
the pathogenesis of chronic pain of musculoskeletal origin in the sense that these cells are tightly 
connected with sensory neurons. 
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3. Materials and experimental procedures 
 
3.1. Materials, reagents and antibodies 
 
Adenosine 5′-triphosphate disodium salt hydrate (ATP), adenosine 5′- diphosphate sodium salt 
(ADP), uridine 5′-triphosphate trisodium salt (UTP), uridine 5′-(trihydrogen diphosphate) sodium salt 
(UDP), adenosine 5′-[β-thio]diphosphate trilithium salt (ADPβS), adenosine 5′-diphosphatase (ADP), 
apyrase, 1-(4,5-Dimethylthiazol-2-yl)-3,5-diphenylformazan  (Thiazolyl blue formazan – MTT), trypsin-
EDTA solution, phosphate buffered saline system (PBS), direct red 80 (C45H26N10Na6O21S6), picric acid 
((O2N)3C6H2OH), amphotericin B, and penicillin/streptomycin were obtained from Sigma (St. Louis, MO, 
USA). 2'-deoxy-N6-methyladenosine 3',5'-bisphosphate tetrasodium salt (MRS 2179), 2-[(2-chloro-5-
nitrophenyl)azo]-5-hydroxy-6-methyl-3-[(phosphonooxy)methyl]-4-pyridinecarboxaldehyde disodium salt 
(MRS 2211), 2-(propylthio)adenosine-5'-O-(β,γ-difluoromethylene)triphosphate tetrasodium salt (AR-
C66096), [[(1R,2R,3S,4R,5S)-4-[6-amino-2-(methylthio)-9H-purin-9-yl]-2,3-dihydroxybicyclo[3.1.0]hex-1-
yl]methyl] diphosphoric acid mono ester trisodium salt (MRS 2365), uridine-5'-tetraphosphate δ-phenyl 
ester tetrasodium salt (MRS 2768), reactive blue-2 (RB-2), and N,N''-1,4-Butanediylbis[N'-(3-
isothiocyanatophenyl)thiourea] (MRS 2578) were obtained from Tocris Cookson Inc. (Bristol, UK). The 
drugs were prepared in DMEM (stock solutions and respectively dilutions) and were stored as frozen 
aliquots at -20ºC. Dimethylsulphoxide (DMSO), hidroxium sodium (NaOH), and glacial acetic acid 
(CH3COOH) were obtained from Merck (Germany).  All primary antibodies used in this study have 
previously been validated ,anti-P2Y4 and anti-P2Y2 was from Abcam (USA), anti-P2Y1, anti-P2Y6, anti-
P2Y12 and anti-P2Y13 was from Alomone (USA), anti-vimentin was from DAKO (UK) and anti-Type I 
collagen was from AbD Serotec (UK). Alexa Fluor 488-labeled anti-rabbit, Alexa Fluor 568-labeled anti-
mouse and the fluorescent calcium indicator Fluo-4NW were supplied by Molecular Probes (Invitrogen, 
USA). Tissue culture plates: 96-well plates were purchased from Corning (USA); FluoroDish plates for 
confocal microscopy were from World Precision Instruments (UK); chamber slides were from Nunc (New 
York, USA). 
 
 
 
 
 
3.2. Cell cultures 
 
Fibroblasts were isolated from subcutaneous tissue of Wistar rats with 2-3 months of age 
(Charles River, Barcelona, Spain). Cells were then obtained by the explant technique and cultured in 
DMEM medium supplemented with 10% fetal bovine serum, 2.5 µg/mL of amphotericin B and 100 U/mL 
of penicillin/streptomycin, at 37ºC in a humidified atmosphere of 95% air and 5% CO2. Medium was 
replaced twice a week.  
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Primary cultures were maintained for 2-3 weeks, until near confluence, when adherent cells were 
enzymatically released with 0.04% trypsin-EDTA solution and 0.025% type I collagenase in phosphate-
buffered saline (PBS), at pH 7.4 during 15-20 minutes. The resultant cell suspension was cultured (104 
cells/cm2) (day 0) and maintained in the same conditions mentioned above. To this end, fibroblast cell 
cultures were established for 28 days in the absence (control) or in the presence of subtype selective P2 
purinoceptor agonists and/or antagonists, which were added to the culture medium at day 1. Drugs were 
renewed in the culture at each medium change, i.e., twice a week.  Cell cultures were routinely 
monitored by phase contrast microscopy and characterized at days 1, 7, 14, 21 and 28 for cell 
viability/proliferation (MTT assay and Live/Dead Cell-Mediated Cytotoxicity kit), total protein content and 
production of collagen type I (Costa et al., 2010). 
 
 
3.3. Cell viability/proliferation 
 
Proliferation studies included the MTT assay and type I collagen determination. 
 
MTT assay. MTT assay consists on the reduction of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium 
bromide (MTT) to a purple formazan reaction product by viable cells. In the last 4h of each test period, 
cells were incubated with 0.5 mg/mL of MTT in the conditions referred above. The medium was carefully 
removed, decanted and the stained product dissolved with DMSO before absorbance (A) determination 
at 600 nm using a microplate reader spectrometer. Results were expressed as A/cm2 (Costa et al., 
2011).  
 
 
 
Figure 9. Microplate reader (Synergy™ HT Multi-Mode Microplate Reader, BioTek Instruments). 
 
 
Type I collagen determination. Sirius Red F3BA was dissolved in saturated aqueous picric acid at a 
concentration of 100 mg/100 mL. Bouin’s fluid (for cell fixation) was prepared in our lab by mixing 15 mL 
saturated aqueous picric acid with 5 mL 35% formaldehyde and 1 mL glacial acetic acid. Cell layers 
were washed twice in PBS 1x before they were fixed with Bouin’s fluid for 1h. The fixation fluid was 
removed by suction and the culture plates were washed by immersion in running tap water for 15 min. 
The culture dishes were allowed to air dry before incubating with Sirius Red dye. Cells were stained for 
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1h under mild shaking on a microplate shaker and the dye was then removed by suction before the 
stained cells were washed twice with 0.01 N hydrochloric acid, so that all non-bound dye could be 
removed. Then the staining was dissolved in 0.1 N sodium hydroxide for 30 min at room temperature 
using a microplate shaker. Optical density was measured at 550 nm (Tulberg- Reinert et al.,1999). 
 
 
3.4. Immunocytochemistry 
 
 Fibroblasts were seeded in chamber slides at a density of 2.5x104 cells/mL and allowed to grow 
for 5-12 days. Cultured cells were fixed in 4% paraformaldehyde (PFA) in phosphate-buffered saline 
(PBS) for 10 minutes, washed 3 times in PBS (10 minutes each) and, subsequently, incubated with 
blocking buffer I (10% FBS, 1% bovine serum albumin (BSA), 0.1% Triton X , 0.05% NaN3) for 1h. 
Primary antibodies, diluted in blocking buffer II (5% FBS, 1% BSA, 0.1% Triton X, 0.05% NaN3), were 
applied [anti-vimentin 1:75 (mouse); anti-type I collagen 1:50 (rabbit); anti-P2Y1 1:50 (rabbit); anti-P2Y2 
1:150 (rabbit); anti-P2Y4 1:75 (rabbit); anti-P2Y6 1:100 (rabbit); P2Y12 1:100 (rabbit); P2Y13 1:25 (rabbit)] 
and the slides incubated overnight at 4ºC. After incubation, cells were washed 3 times in PBS 1X (10 
minutes each). The Alexa Fluor 488 (anti-rabbit) and Alexa Fluor 568 (anti-mouse) secondary antibodies 
were diluted in blocking buffer II (5% FBS, 1% BSA, 0.1% Triton X) and applied for 1h at dark. A last 
wash was performed with PBS 1X and glass slides mounted with VectaShield medium and stored at 
4ºC. Observations were performed and analysed with a laser-scanning confocal microscope (Olympus 
FV1000, Japan) (Alqallaf et al., 2009). 
 
 
3.5. Presentation of data and statistical analysis 
 
 Data are expressed as mean ± S.E.M. from an n number of experiments/cells. Data from different 
individuals were evaluated using t-test and one-way analysis of variance (ANOVA) and no significant 
differences in the pattern of cell behavior were found. Statistical differences found between control and 
drug-treated cultures were determined by Bonferroni´s method. P values <0.05 were considered to 
represent significant differences. 
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4. Results  
 
4.1. Characterization of fibroblast cells in culture by immunocytochemistry 
 
Cultured cells exhibited positive immunoreactivity against vimentin, the most frequently found 
intermediate filament in fibroblasts, which has been considered a reliable fibroblast marker (Fig.10a, red) 
(Agocha & Eghbali-Webb, 1997). Cells also stained positive for type I collagen (fig. 10b, green), which is 
highly produced by activated fibroblasts (Agocha & Eghbali-Webb, 1997). Type I collagen labeling is 
concentrated around the nucleus, indicating that it is being intensively synthesized in the rough 
endoplasmic reticulum and stored at the Golgi apparatus of these cells (Gartner et al., 2007). 
Furthermore, cultured cells are elongated and exhibited a spindle-shape morphology that is 
characteristic of activated fibroblasts (Freshney, 2006; Gartner et al., 2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
4.2. Characterization of P2 purinoceptors on fibroblast cells involved in proliferation 
and extracellular matrix production 
 
Preliminary results from our group regarding the influence of P2 purinoceptors on intracellular 
Ca2+ signaling in cultured fibroblasts from the rat subcutaneous tissue showed that these cells are 
sensitive to adenine and uridine nucleotides, namely ADP and UTP (Certal et al., 2011). Therefore, we 
decided to investigate the role of UTP- and ADP-sensitive P2 receptors on cell proliferation and 
extracellular matrix production.  To this end, fibroblasts of the rat subcutaneous connective tissue were 
cultured for 28 days, during which drugs were routinely added to the cell culture medium. 
 
Figure 10. Immunocytochemical staining of fibroblasts isolated from the rat subcutaneous 
tissue. (a) Cells exhibited positive immunoreactivity against vimentin, which has been 
described as a reliable fibroblast marker (red). (b) Most of the cells also stained positive to 
type I collagen (green), which is highly produced by activated fibroblasts. Note that cells 
exhibit a spindle-shape morphology that is characteristic of activated fibroblasts. Images 
obtained by confocal laser scanning microscopy. Scale bar 20 µm. 
a b 
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4.2.1 Effects of uridine nucleotides on fibroblast cells proliferation and type I collagen 
synthesis: P2Y6 receptors promote fibroblasts proliferation, whereas type I 
collagen synthesis is negatively modulated via P2Y2 receptors 
 
To assess the role of uridine nucleotides on the fibroblasts proliferation and type I collagen 
synthesis, we tested UTP (0.3-100 µM) as a non-selective agonist for P2Y2, P2Y4 and P2Y6 purinergic 
receptors. For comparison purpose, we also tested the selective P2Y2 agonist MRS 2768 (3-10 µM). 
The results showed that continuous incubation of UTP (0.3-100 M, n=5) concentration-
dependently increased fibroblasts proliferation (evaluated by the MTT reduction values) from the first 
week onwards, reaching its maximal value at culture day 14 (Fig. 11A).  UTP (0.3-100 M, n=5) also 
increased the synthesis of type I collagen above the control levels (Fig. 11B). Conversely, the selective 
P2Y2 agonist, MRS 2768 (10 µM, n=3), was devoid of effect in what concerns proliferation (Fig. 11C), but 
this drug significantly (P<0.05) decreased type I collagen synthesis, particularly at incubation days 21 
and 28 (Fig. 11D).  
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Figure 11. (A) Variation of cell viability/proliferation of rat fibroblasts continuously exposed to UTP (0.3-100 µM, 
n=5) during 28 days. (B) Variation of type I collagen production by rat fibroblasts continuously exposed to UTP (0.3-
100 µM, n=4) during 28 days. (C) Variation of cell viability/proliferation production of rat fibroblasts continuously 
exposed to the P2Y2 selective agonist, MRS 2768 (3-10 µM, n=4) during 28 days. (D) Variation of type I collagen 
production by rat fibroblasts continuously exposed to the P2Y2 selective agonist, MRS 2768 (3-10 µM, n=3) during 
28 days. (A) and (C) The ordinates represent changes in cell viability/proliferation measured by the MTT assay. (B) 
and (D) The ordinates represent changes in type I collagen production measured using the Sirius Red assay. Each 
point represents pooled data from an n number of animals; 3-5 replicas were performed for each individual 
experiment. The vertical bars represent S.E.M.. *P<0.05 represent significant differences as compared to the 
control value. 
 
Since the increase in type I collagen synthesis was proportional to the increase in the amount of 
cells in the culture (fibroblasts proliferation), we may speculate that such an increase could be related to 
the increase in the cell number rather than a higher synthetic activity. Thus, we performed a more 
detailed data analysis, in which we normalized type I collagen production taking into consideration the 
MTT values obtained at the same time points, and we observed no longer significant differences 
between control and UTP-exposed cells (Table 1).  
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Table 1. Type I collagen production taking into consideration the MTT values obtained at the same time 
points.  
 Type I collagen (λ=550 nm) 
 
Type I collagen (λ=550 nm) / 
MTT ( λ=600 nm) 
Days Control UTP (100 µM) Control UTP (100 µM) 
14 0,23 ± 0,01 0,26 ± 0,01 (n.s.) 0,38 ± 0,02 0,35 ± 0,03 (n.s.) 
21 0,25 ± 0,02 0,30 ± 0,01 (*) 0,43 ± 0,02 0,40 ± 0,01 (n.s.) 
28 0,25 ± 0,01 0,32 ± 0,01 (*) 0,66 ± 0,06 0,69 ± 0,08 (n.s.) 
 
 
 
Discounting the contribution of MRS 2768-sensitive P2Y2 receptors, UTP (100 µM)-induced 
increase in cells proliferation could be due to P2Y4 and/or P2Y6 receptor activation. Therefore, we 
designed experiments to evaluate which of these purinoceptor(s) could be mediating the facilitatory 
effect of UTP on fibroblast cells proliferation using RB-2 (10 µM), which is a non-selective P2 receptor 
antagonist acting preferentially on the P2Y4 subtype, and MRS 2578 (100 nM), which is a selective P2Y6 
antagonist. As shown in Fig. 12, RB-2 (10 µM, n=5) did not modify the effect of UTP (100 µM) (Fig. 12A), 
which was, in turn, significantly attenuated by the presence of the P2Y6 antagonist, MRS 2578 (100 nM, 
n=4) (Fig. 12B). 
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Figure 12. Variation of cell viability/proliferation of rat fibroblasts continuously exposed during 28 days to UTP (100 
µM, n=5) in the absence and in the presence of the P2 non-selective antagonist RB-2 (10 µM, n=5), which 
antagonizes the P2Y4 purinoceptor (A), and of the P2Y6 selective antagonist, MRS 2578 (100 nM, n=4) (B).The 
ordinates represent changes in cell viability/proliferation measured by the MTT assay. Each point represents 
pooled data from an n number of animals; 4-5 replicas were performed for each individual experiment. The vertical 
bars represent S.E.M.. * p<0.05 represent significant differences between the agonist comparing to the control. # 
p<0.05 represent significant differences between the agonist in the presence of the antagonist comparing to the 
agonist alone. 
. 
 
Considering that the UTP mediated response may be due to P2Y6 receptor activation, we 
decided to test the native P2Y6 receptor ligand, UDP (0.3-100 µM), which may result from the catabolism 
of UTP through the ectonucleotidase pathway.  Unexpectedly, UDP (0.3-100 µM) did not mimic the UTP-
induced response (Fig 13). 
 
 
. 
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Figure 13. (A) Variation of cell viability/proliferation of rat fibroblasts continuously exposed to UDP (0.3-100 µM, 
n=3-4) during 28 days. (B) Variation of type I collagen production by rat fibroblasts continuously exposed to UDP 
(0.3-100 µM, n=3) during 28 days. (A) The ordinates represent changes in cell viability/proliferation measured by 
the MTT assay. (B) The ordinates represent changes in type I collagen production measured using Sirius Red. 
Each point represents pooled data from an n number of animals; 3-4 replicas were performed for each individual 
experiment. The vertical bars represent S.E.M..  
 
In order to confirm the expression of P2 purinoceptors sensitive to uridine nucleotides in 
fibroblast cells in culture, we performed immunocytochemistry experiments. Fibroblasts showed 
a positive immunoreactivity against the P2Y2 and P2Y6 receptors exhibiting a 
cytoplasmic/membrane labeling pattern, which is typical for those receptors in many different 
cells (Fig. 14A and 14C). On the contrary, labeling with the antibody against the P2Y4 receptor 
exhibited a nuclear pattern (Fig. 14B), thus supporting our hypothesis that P2Y4 receptors might 
not be involved in the proliferation and type I collagen synthesis by these cells.  
 
 
 
 
 
P2Y6
C
P2Y2
A
P2Y4
B
 
Figure 14. Immunocytochemical staining of fibroblasts isolated from the rat subcutaneous tissue. Cells exhibit a 
cytoplasmic/membrane pattern labeling for P2Y2 (A) and P2Y6 (C) receptors. Conversely, only a nuclear staining 
was observed to the antibody against the P2Y4 (B) receptor. Images obtained using a laser-scanning confocal 
microscope (Olympus FV1000, Japan). Scale bar 20 µm. 
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4.2.2. Effects of adenine nucleotides on fibroblast cells proliferation and type I collagen 
synthesis: activation of P2Y1 receptors enhance, whereas P2Y13 receptors 
decrease, type I collagen synthesis 
 
To investigate the involvement of ADP-sensitive P2 receptors on cell proliferation and 
extracellular matrix production, fibroblast cultures were continuously incubated (during 28 days) with the 
stable ADP analogue, ADPβS (10-100 µM). Results obtained with ADPβS (10-100 µM, n=3-6) showed 
no significant (P>0.05) differences in fibroblast cells proliferation / viability given by the MTT values (Fig. 
15A). Continuous incubation with ADPβS (10-100 µM, n=2-5), concentration-dependently increased type 
I collagen production by fibroblasts from the third week onwards, reaching its maximal value at day 28 
(four weeks in culture) (P<0.05, day 21 and 28) (Fig. 15B).  
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Figure 15. (A) Variation of cell viability/proliferation of rat fibroblasts continuously exposed to ADPβS (10 µM, n=3; 
100 µM, n=6) during 28 days. (B) Variation of type I collagen production by rat fibroblasts continuously exposed to 
ADPβS (10 µM, n=2; 100 µM, n=5) during 28 days. (A) The ordinates represent changes in cell 
viability/proliferation measured by the MTT assay. (B)The ordinates represent changes in type I collagen 
production measured using Sirius Red. Each point represents pooled data from an n number of animals; 2-6 
replicas were performed for each individual experiment. The vertical bars represent S.E.M.. * p<0.05 represent 
significant differences between the agonist comparing to the control. 
 
Considering that prolonged exposure to ADPβS (100 µM) induced a significant increase in type I 
collagen synthesis, we proceeded to the evaluation of which purinoceptor(s) that could be mediating this 
effect. Therefore, we tested ADPβS (100 µM) in the presence of MRS 2179 (0.3 µM), AR-C 66096 (0.1 
µM), and MRS 2211 (10 µM), which antagonize selectively ADP-sensitive P2Y1, P2Y12 and P2Y13 
receptors, respectively. As shown in Fig. 16, the facilitatory effect of ADPβS (100 µM) was significantly 
attenuated in the presence of the P2Y1 antagonist, MRS 2179 (0.3 µM, n=3) (Fig. 16A), without being 
affected by the P2Y12 antagonist, AR- C 66096 (0.1 µM, n=3) (Fig. 16B). In contrast, MRS 2211 (10 µM, 
n=2) potentiated the effect of ADPβS (100 µM) on type I collagen synthesis (Fig. 16C), thus indicating 
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that the P2Y1-receptor-induction of type I collagen synthesis may be partially counteracted by 
synchronous activation of the inhibitory P2Y13 receptor. 
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Figure 16. Variation of type I collagen production by rat fibroblasts continuously exposed during 28 days to ADPβS 
(100 µM, n=5) in the absence and in the presence of the P2 non-selective antagonist MRS 2179 (0.3 µM, n=3), 
which antagonizes the P2Y1 purinoceptor (A); in the presence of the P2Y12 selective antagonist, AR-C 66096 (0.1 
µM, n=3) (B), and in the presence of the P2Y13 selective antagonist, MRS 2211 (10 µM, n=2) (C). The ordinates 
represent changes in type I collagen production measured using Sirius Red. Each point represents pooled data 
from an n number of animals; 2-5 replicas were performed for each individual experiment. The vertical bars 
represent S.E.M.. * p<0.05 represent significant differences between the agonist comparing to the control. # p<0.05 
represent significant differences between the agonist in the presence of the antagonist comparing to the agonist 
alone. 
 
We performed immunocytochemistry experiments to evaluate the expression of ADP-sensitive 
P2Y1, P2Y12 and P2Y13 receptors in cultured fibroblasts of the rat subcutaneous tissue. These cells 
exhibited immunoreactivity to P2Y1 and P2Y13 receptors with a cytoplasmic/membrane staining pattern 
(Fig. 17A and 17C). These findings support the hypotheses that both receptors may be implicated in type 
I collagen synthesis in rat fibroblasts. Moreover, we observed a nuclear staining pattern with the antibody 
against P2Y12 receptors, thus indicating that this receptor subtype might not be involved in proliferation 
and type I collagen production by these cells.  
 
 
P2Y1 P2Y12 P2Y13
A B C
 
Figure 17. Immunocytochemical staining of fibroblasts isolated from the rat subcutaneous tissue. Cells exhibit a 
cytoplasmic/membrane pattern labeling for P2Y1 (A) and P2Y13 (C) receptors. Conversely, only a nuclear staining 
was observed to the antibody against the P2Y12 (B) receptor. Images obtained using a laser-scanning confocal 
microscope (Olympus FV1000, Japan). Scale bar 20 µm. 
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5. Discussion 
 
Extracellular nucleotides are well recognized as important signaling molecules mediating a wide 
range of functions, of which proliferation and extracellular matrix remodeling is included (Burnstock, 
2002). Cardiac fibroblasts have been recently implicated in the origin of myocardial fibrosis due to an 
increase of collagen synthesis induced by purines (Epperson et al., 2009; Braun et al., 2010). As well, 
the remodeling of superficial fascia may be an important link to a pathogenic mechanism leading to 
chronic pain, such as low back pain and fibromyalgia (Langevin & Sherman, 2007). To our knowledge, 
the purinergic signaling mediating fascia remodeling has never been clarified. Therefore, in this study we 
investigated the role of ADP- and UTP/UDP-sensitive receptors on the proliferation and extracellular 
matrix production by cultured fibroblasts of rat superficial fascia, which were maintained in standard 
conditions for 28 days.  
It is well established that UTP can exert its effects acting directly through P2Y2 and/or P2Y4, and 
indirectly via P2Y6, by UDP formed from the extracellular catabolism of UTP by ectonucleotidases 
(Burnstock, 2007). Data show that subtype-specific uridine nucleotide-sensitive receptors produce 
distinct actions on fibroblasts from the rat superficial fascia. Prolonged exposure to UTP (0.3-100 M) 
concentration-dependently increased fibroblast cells proliferation and raised the synthesis of type I 
collagen. However, the increase in the collagen synthesis must be seen as arising from the increase in 
the number of cells produced by UTP rather than by an increase on the ability of fibroblasts to synthesize 
proteins of the extracellular matrix, namely type I collagen. This conclusion was drawn from the fact that 
augmentation of collagen synthesis in the presence of UTP was proportional to the increase in the 
amount of fibroblast cells in the cultures at given time points. Consequently, we observed no significant 
differences when type I collagen values were normalized to the proliferation status of each culture, which 
was given by the MTT assay. In contrast, selective activation of the P2Y2 receptor with MRS 2768 
reduced type I collagen synthesis without affecting fibroblasts proliferation. These contradictory effects 
led us to hypothesize that the proliferative effect of UTP (100 µM) on rat fibroblasts could result from the 
activation of P2Y4 and/or P2Y6 receptors. To confirm this hypothesis, we tested the effect of UTP (100 
µM) in the presence of RB-2 (10 µM, a non-selective P2 receptor antagonist with affinity for P2Y4 
receptors), and MRS 2578 (100 nM, a selective P2Y6 receptor antagonist). The results we obtained 
demonstrate that the enhanced proliferation induced by UTP (100 µM) might be due P2Y6 activation, as 
it was attenuated by MRS 2578 (100 nM), whereas RB-2 (10 µM) was without effect.  
All membrane-bound ecto-NTPDases dephosphorylate UTP with a significant accumulation of 
UDP that is the natural ligand of the P2Y6 receptor (Kukulski et al., 2011). Therefore, we decided to test 
the effect of UDP (0.3-100 µM) on fibroblast cells proliferation and type I collagen synthesis. 
Surprinsingly, UDP (0.3-100 µM) was unable to mimic UTP-induced responses. Taken together these 
findings suggest that P2Y6 activation may be fine-tuning modulated by ecto-enzymes, which might be 
due to (1) a close proximity of ecto-NTPDases to the receptor, leading to a very selective local regulation 
of the nucleotide levels, or (2) to a close relationship of the enzymes with the receptor by forming an 
hetero-oligomer. It is well accepted that G protein-coupled receptors (GPCRs) arrange into dimers or 
higher-order oligomers that may modify various functions of GPCRs. In addition, it has also been 
described that GPCRs may form hetero-oligomers with enzymes responsible for nucleotide hydrolysis 
38 
 
(reviewed by Nakata et al., 2010), which could explain our results. Because of the methodological 
difficulties associated with demonstrating any physiological significance of dimerization in native 
systems, only limited information is available on the physiological relevance of the various GPCR dimers 
identified to date in transfected cell culture systems. However, various roles for dimeric GPCRs have 
been described, including enhanced surface receptor expression, alterations in the potency of receptor 
agonists, and changes in ligand specificity. Thus, it is likely that the physiological effects of nucleotides 
are mediated by a membrane-contained network of appropriate receptors and enzymes, and not only by 
isolated receptors (reviewed by Nakata et al., 2010). 
Interestingly, the uridine nucleotide-sensitive P2Y2 receptor activation seems to induce a 
divergent response comparing to P2Y6. Our data indicate that P2Y2 receptor activation reduces the 
production of type I collagen without interfering the ability of fibroblasts to proliferate in culture. A 
previous study using osteoblast progenitor cells reported similar negative effects on bone nodule 
formation operated by P2Y2 activation. The authors also argued that this finding was most likely due to 
inhibitory effects on cell aggregation and/or collagen/matrix deposition prior to mineralization (Hoebertz 
et al., 2002). Although this report is related to a different cell type, there is a common feature between 
osteoblasts and fibroblasts, namely the active extracellular matrix synthesis and remodeling ability 
characterizing these cells.  
Taken together, these findings support the hypothesis that uridine-sensitive P2Y2 and P2Y6 
receptors play opposing roles, in which P2Y2 have a preventive function on fibrotic response by reducing 
type I collagen synthesis, whereas P2Y6 prompts a pro-fibrotic reaction due to an increase in fibroblasts 
proliferation. This outcome led us to postulate that two different G proteins may be regulating both 
distinct responses. Like what has been reported regarding cardiac fibrosis and hypertrophy, namely that 
the G12/13-mediated pathway regulates fibrosis, and the Gq/11-mediated pathway regulates hypertrophy 
(Nishida et al., 2008), our results suggest that two different transduction mechanisms might be involved 
in the effects mediated by P2Y2 and P2Y6 receptor. It is well established that P2Y2 and P2Y6, as well as 
P2Y1 and P2Y4 receptors, couple to Gαq/11 proteins to increase inositol triphosphate (IP3) and 
diacylglycerol, second messengers for calcium release from intracellular stores and protein kinase C 
(PKC) activation, respectively. Interestingly, the possibility that P2Y2 receptor could negatively couple to 
adenylate cyclase through the Gi/o protein α-subunits was also mentioned (Burnstock, 2007). 
Considering this interesting fact, we hypothesize that P2Y2-induced type I collagen synthesis decrease 
could be mediated by a Gi/o protein α-subunits, whereas P2Y6-evoked fibroblasts proliferation increase 
would occur due to the activation of a Gq/11 protein α-subunits. However, this hypothesis requires further 
investigation. 
In addition to the functional role of uridine nucleotides on fibroblasts in culture, we investigated 
the possible involvement of ADP-sensitive P2 receptors on cell proliferation and extracellular matrix 
production. To this end, fibroblast cultures were continuously incubated (during 28 days) with the stable 
ADP analogue, ADPβS (10-100 µM), which activate preferentially P2Y1, P2Y12 and P2Y13 receptors. In 
contrast to the response obtained with uridine nucleotides, proliferation of fibroblasts in culture was 
unaffected by ADPβS (10-100 µM). This finding was unexpected since ADP has been claimed to 
modulate cell proliferation in different cell types, like keratinocytes and pulmonary fibroblasts (reviewed 
by Gendaszewska-Darmach & Kucharska, 2011). Nevertheless, a prolonged exposure to ADPβS (10-
100 µM) concentration-dependently increased type I collagen synthesis. Subtype characterization of the 
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receptor(s) involved in ADPβS (100 µM)-induced type I collagen production by fibroblasts of the rat 
subcutaneous tissue was performed using selective P2Y1, P2Y12 and P2Y13 receptor antagonists, 
respectively MRS 2179 (300 nM), AR-C 66096 (0.1 µM) and MRS 2211 (10 µM). Surprisingly, ADPβS-
induced production of type I collagen was attenuated by MRS 2179 (300 nM), but it was potentiated by 
MRS 2211 (10 µM), thus indicating opposed roles for P2Y1 and P2Y13 receptors in fibroblast cells 
maturation. Since AR-C 66096 (100 nM) was devoid of effect, one may exclude a significant P2Y12 
receptor contribution. Thus, data suggest that activation of the P2Y1 receptor promote type I collagen 
synthesis, but this effect may be partially counteracted by P2Y13 receptor activation. Considering that 
P2Y13 is primarily coupled to Gi/o protein α-subunits, this finding supports our previous hypothesis 
regarding the contribution of the inhibitory P2Y2 receptor, thus indicating that inhibition of adenylate 
cyclase triggers a common pathway responsible for the reduction of type I collagen synthesis in rat 
fibroblasts. However, according to what we have mentioned before, P2Y1 couple to Gαq/11 proteins which 
should have interfered with proliferation rather than with type I collagen synthesis. One may, however, 
hypothesize that the P2Y13 receptor may interact with P2Y1 receptor at the second messenger system 
level. G-protein-mediated signal transduction is a complex signaling pathway with diverging and 
converging transduction steps at each coupling interface (Gudermann et al., 1997). It is now recognized 
that interactions between G protein-coupled receptors can occur not only through the formation of 
oligomers but also downstream the receptor at the second messengers level, a process that is known as 
receptor cross-talk (Burnstock, 2007). Therefore, one may speculate that the response of fibroblasts to 
ADPβS might involve a cross-talk between P2Y13 and P2Y1. 
In summary, a delicate balance between the activation of P2Y2 and P2Y6, as well as P2Y13 and 
P2Y1 purinoceptors, might regulate fibroblast’s induced superficial fascia remodeling. Targeting the 
pathways leading to fibrosis may represent an opportunity to clarify its involvement in the pathogenesis 
of musculoskeletal chronic pain and it may be useful for designing novel therapeutic strategies to 
overcome this disease. 
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